NVO Stock Down as Medicare Selects Semaglutide Drugs for Price Cuts
Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...
This 'illegal' weight loss jab sold on TikTok could send you to hospital
Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...
Dark side of fat loss jabs flogged for £40 on TikTok laid bare – as 100s of Brits hospitalised with ‘serious reaction’
FAT loss jabs have been spotted flogged for £40 on TikTok as hundreds of Brits have been hospitalised with “serious reactions ...
Zacks.com on MSN4h
Company News for Jan 20, 2025
Intel Corporation (INTC) shares surged 9.3% on takeover speculation following its CEO's December departure. Novo Nordisk A/S (NVO) shares fell 5.3% after Medicare included semaglutide, the key ...
LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.
Novo Nordisk’s high-dose Wegovy increases weight loss and remains safe
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.